MX2021001165A - Agonistas sesgados de interferon-gamma. - Google Patents

Agonistas sesgados de interferon-gamma.

Info

Publication number
MX2021001165A
MX2021001165A MX2021001165A MX2021001165A MX2021001165A MX 2021001165 A MX2021001165 A MX 2021001165A MX 2021001165 A MX2021001165 A MX 2021001165A MX 2021001165 A MX2021001165 A MX 2021001165A MX 2021001165 A MX2021001165 A MX 2021001165A
Authority
MX
Mexico
Prior art keywords
gamma
ifn
methods
mediated
interferon
Prior art date
Application number
MX2021001165A
Other languages
English (en)
Spanish (es)
Inventor
Juan Luis Mendoza
Kenan Christopher Garcia
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of MX2021001165A publication Critical patent/MX2021001165A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7156—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2021001165A 2018-07-30 2019-07-29 Agonistas sesgados de interferon-gamma. MX2021001165A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862712128P 2018-07-30 2018-07-30
PCT/US2019/043977 WO2020028275A1 (en) 2018-07-30 2019-07-29 Interferon-gamma biased agonists

Publications (1)

Publication Number Publication Date
MX2021001165A true MX2021001165A (es) 2021-07-15

Family

ID=69230882

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021001165A MX2021001165A (es) 2018-07-30 2019-07-29 Agonistas sesgados de interferon-gamma.

Country Status (7)

Country Link
US (1) US12410226B2 (https=)
EP (1) EP3830115A4 (https=)
JP (2) JP2021531814A (https=)
AU (1) AU2019313339A1 (https=)
CA (1) CA3108066A1 (https=)
MX (1) MX2021001165A (https=)
WO (1) WO2020028275A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020028275A1 (en) 2018-07-30 2020-02-06 The Board Of Trustees Of The Leland Stanford Junior University Interferon-gamma biased agonists
WO2022212525A2 (en) 2021-03-30 2022-10-06 City Of Hope Car t cell therapy and ifn gamma

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JPS6124599A (ja) * 1984-07-11 1986-02-03 Kyowa Hakko Kogyo Co Ltd 新規ヒトインタ−フエロン−ｒポリペプチド誘導体
US4845196A (en) 1985-06-24 1989-07-04 G. D. Searle & Co. Modified interferon gammas
JP2969461B2 (ja) 1988-07-23 1999-11-02 株式会社林原生物化学研究所 ヒトγ−インターフェロンとその製造方法並びに用途
US5858784A (en) 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
DE19535853C2 (de) * 1995-09-18 1999-04-01 Fraunhofer Ges Forschung Varianten des rekombinanten humanen Interferon-gamma, Verfahren zu ihrer Herstellung und ihre Verwendung
SK8292002A3 (en) 1999-11-12 2002-12-03 Maxygen Holdings Ltd A conjugate exhibiting interferon gamma activity, nucleotide sequence encoding for a polypeptide fraction of conjugate, an expression vector and a host cell containing nucleotide sequence, pharmaceutical composition comprising the same and use thereof
US7038015B2 (en) * 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
JP2004522803A (ja) 2001-06-29 2004-07-29 マキシゲン・エイピーエス インターフェロン製剤
AU2003239774A1 (en) * 2002-07-03 2004-01-23 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
EP1877434A2 (en) * 2005-05-04 2008-01-16 Nautilus Biotech Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
US8617531B2 (en) 2006-12-14 2013-12-31 Bolder Biotechnology, Inc. Methods of making proteins and peptides containing a single free cysteine
US20080260820A1 (en) * 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides
CA2809747C (en) 2010-08-30 2018-05-01 Roberto Testi Compositions and methods for treating friedreich's ataxia with interferon gamma
US10466359B2 (en) * 2013-01-01 2019-11-05 Inuitive Ltd. Method and system for light patterning and imaging
CA3040802A1 (en) 2016-10-24 2018-05-03 Orionis Biosciences Nv Targeted mutant interferon-gamma and uses thereof
WO2020028275A1 (en) 2018-07-30 2020-02-06 The Board Of Trustees Of The Leland Stanford Junior University Interferon-gamma biased agonists
EP3883585A4 (en) 2018-11-20 2022-12-14 Innovative Cellular Therapeutics Holdings, Ltd. MODIFIED CELL EXPRESSING THERAPEUTIC AND USES THEREOF

Also Published As

Publication number Publication date
JP2021531814A (ja) 2021-11-25
CA3108066A1 (en) 2020-02-06
WO2020028275A1 (en) 2020-02-06
US20210309707A1 (en) 2021-10-07
US12410226B2 (en) 2025-09-09
EP3830115A1 (en) 2021-06-09
EP3830115A4 (en) 2022-08-10
JP2024137947A (ja) 2024-10-07
AU2019313339A1 (en) 2021-03-11

Similar Documents

Publication Publication Date Title
MX2021013197A (es) Cicloalquilos sustituidos como moduladores de la vía integrada del estrés.
CO2021008998A2 (es) Amidas de pirrolidina iii sustituidas
CR20110520A (es) Acetamidas sustituidas por n-(hetero)-arilo y 2-(hetero)-arilo para usarse como moduladoras de la señalización de wnt
CL2020000375A1 (es) Activadores de piruvato quinasas para usar en el tratamiento de trastornos en la sangre.
CO2020006248A2 (es) Moduladores de la vía de estrés integrada
ECSP20027553A (es) Moduladores de la vía de estrés integrada
MX389514B (es) Compuestos útiles como moduladores de canal receptor 8 de potencial transitorio de melastatina (trpm8).
PE20191150A1 (es) Receptores de celulas t con apareamiento mejorado
CR20160321A (es) Modulares de tetrahidropiridopirazinas de gpr6
UY37958A (es) Moduladores de la vía de estrés integrada
JO3719B1 (ar) 4- أوكسو-4،3- داي هيدرو-3،2،1- بنزوترايازينات كمواد ضابطة لأجل gpr139
ECSP19055169A (es) Compuestos moduladores del receptor de hidrocarburos de arilo (ahr)
HN2011002272A (es) Derivados de indol como antagonistas del receptor crth2
ECSP13012410A (es) Composiciones y métodos para modular la vía de señalización de wnt
MX2021015631A (es) Moduladores del receptor arilo y metodos para elaborar y usar los mismos.
CR20110103A (es) Heteroarilos sustituidos
ECSP19055179A (es) Compuestos moduladores del receptor de hidrocarburos de arilo (ahr)
DOP2010000149A (es) Derivados de alcanos azabiciclicos sustituidos con biarilo como moduladores de la actividad de los receptores nicotinicos de acetilcolina
CO2021016003A2 (es) Amidas de pirazolo-piridina sustituidas y su uso como moduladores del receptor glun2b
AR114517A1 (es) Transmisión de uci urllc
UY33118A (es) Indazoles aminotiazolona sustituidos como moduladores del receptor a relacionado con estrógenos
MX2021001165A (es) Agonistas sesgados de interferon-gamma.
CO2022008348A2 (es) Carboxamidas de tiofeno sustituidas y derivados de estas como microbicidas
CR20140424A (es) Compuestos de cromano sustituidos como moduladores del receptor sensible al calcio
UA117779C2 (uk) Піразини як модулятори gpr6